Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118241) titled 'Multidimensional Validation of Novel Biomarkers for Organ Injury in Cancer Immunotherapy' on Feb. 3.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences
Condition:
Cancer
Intervention:
ICIs-irAEs Group:None
ICIs-non-irAEs Group:None
Non-ICIs Group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-15
Target Sample Size: ICIs-irAEs Group:300;ICIs-non-irAEs Group:100;Non-ICIs Group:100;Healthy Group:100;
Countries of Recrui...